These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 37933874)

  • 1. Genetically Engineered Cell Membrane-Coated Nanoparticles with High-Density Customized Membrane Receptor for High-Performance Drug Lead Discovery.
    Bu Y; Wu D; Zhao Y; Wang G; Dang X; Xie X; Wang S
    ACS Appl Mater Interfaces; 2023 Nov; ():. PubMed ID: 37933874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immobilized cells on microcarriers for efficient and biomimetic screening of active compounds acting on FGFR4 from Fructus evodiae.
    Wei F; Gou X; Wang S
    J Pharm Biomed Anal; 2024 Sep; 248():116284. PubMed ID: 38908234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inside-Out-Oriented Cell Membrane Biomimetic Magnetic Nanoparticles for High-Performance Drug Lead Discovery.
    Bu Y; Zhang X; Zhu A; Li L; Xie X; Wang S
    Anal Chem; 2021 Jun; 93(22):7898-7907. PubMed ID: 34038073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering.
    Krishnan N; Jiang Y; Zhou J; Mohapatra A; Peng FX; Duan Y; Holay M; Chekuri S; Guo Z; Gao W; Fang RH; Zhang L
    Nat Nanotechnol; 2024 Mar; 19(3):345-353. PubMed ID: 37903891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precise assembly of inside-out cell membrane camouflaged nanoparticles
    Zhang X; Zhen X; Yang Y; Feng Q; Yuan W; Xie X
    Acta Pharm Sin B; 2023 Feb; 13(2):852-862. PubMed ID: 36873174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging Approaches to Functionalizing Cell Membrane-Coated Nanoparticles.
    Ai X; Wang S; Duan Y; Zhang Q; Chen MS; Gao W; Zhang L
    Biochemistry; 2021 Apr; 60(13):941-955. PubMed ID: 32452667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using design of experiments (DoE) to optimize performance and stability of biomimetic cell membrane-coated nanostructures for cancer therapy.
    Ferreira NN; Miranda RR; Moreno NS; Pincela Lins PM; Leite CM; Leite AET; Machado TR; Cataldi TR; Labate CA; Reis RM; Zucolotto V
    Front Bioeng Biotechnol; 2023; 11():1120179. PubMed ID: 36815878
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell membrane-coated nanoparticles: research advances.
    Zou S; Wang B; Wang C; Wang Q; Zhang L
    Nanomedicine (Lond); 2020 Mar; 15(6):625-641. PubMed ID: 32098564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Novel 7-Azaindole Derivatives as Selective Covalent Fibroblast Growth Factor Receptor 4 Inhibitors for the Treatment of Hepatocellular Carcinoma.
    Zhong Z; Shi L; Fu T; Huang J; Pan Z
    J Med Chem; 2022 May; 65(10):7278-7295. PubMed ID: 35549181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanomaterial Biointerfacing via Mitochondrial Membrane Coating for Targeted Detoxification and Molecular Detection.
    Gong H; Zhang Q; Komarla A; Wang S; Duan Y; Zhou Z; Chen F; Fang RH; Xu S; Gao W; Zhang L
    Nano Lett; 2021 Mar; 21(6):2603-2609. PubMed ID: 33687220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coating nanoparticles with cell membranes for targeted drug delivery.
    Gao W; Zhang L
    J Drug Target; 2015; 23(7-8):619-26. PubMed ID: 26453159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanoparticle functionalization with genetically-engineered mesenchymal stem cell membrane for targeted drug delivery and enhanced cartilage protection.
    Zhang X; Sun Y; Chen W; Yang J; Chen J; Chen S
    Biomater Adv; 2022 May; 136():212802. PubMed ID: 35929288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel cell membrane affinity sample pretreatment technique for recognition and preconcentration of active components from traditional Chinese medicine.
    Bu Y; He X; Hu Q; Wang C; Xie X; Wang S
    Sci Rep; 2017 Jun; 7(1):3569. PubMed ID: 28620157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mesoporous silica nanoparticle nanocarriers: biofunctionality and biocompatibility.
    Tarn D; Ashley CE; Xue M; Carnes EC; Zink JI; Brinker CJ
    Acc Chem Res; 2013 Mar; 46(3):792-801. PubMed ID: 23387478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations for efficient surface functionalization of nanoparticles with a high molecular weight protein as targeting ligand.
    Thalhauser S; Breunig M
    Eur J Pharm Sci; 2020 Dec; 155():105520. PubMed ID: 32822809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor-mediated targeting of magnetic nanoparticles using insulin as a surface ligand to prevent endocytosis.
    Gupta AK; Berry C; Gupta M; Curtis A
    IEEE Trans Nanobioscience; 2003 Dec; 2(4):255-61. PubMed ID: 15376916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual-mixed/CMC model for screening target components from traditional Chinese medicines simultaneously acting on EGFR & FGFR4 receptors.
    Fu J; Lv Y; Jia Q; Lin Y; Han S
    Talanta; 2019 Jan; 192():248-254. PubMed ID: 30348386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetically engineered cell membrane-coated nanoparticles for antibacterial and immunoregulatory dual-function treatment of ligature-induced periodontitis.
    Deng Y; Ren M; He P; Liu F; Wang X; Zhou C; Li Y; Yang S
    Front Bioeng Biotechnol; 2023; 11():1113367. PubMed ID: 36761293
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug Targeting
    Wang S; Duan Y; Zhang Q; Komarla A; Gong H; Gao W; Zhang L
    Small Struct; 2020 Oct; 1(1):. PubMed ID: 33817693
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.